Related Experiment Video
Updated: Sep 7, 2025
07:22
Minimally Invasive Murine Laryngoscopy for Close-Up Imaging of Laryngeal Motion During Breathing and Swallowing
Published on: December 1, 2023
641
Laryngeal Dysfunction and Acute Organophosphorus Poisoning
Chulananda Goonasekera1, Lakshman Karalliedde2
1Department of Anaesthetics, King's College Hospital NHS Foundation Trust, Institute of Childhealth, University College London, London, England, United Kingdom.
Summary
Acute organophosphorus poisoning can cause laryngeal dysfunction, impacting breathing. Early recognition and management are crucial for patient outcomes in critical care settings.
Area of Science:
- Critical Care Medicine
- Toxicology
- Otolaryngology
Background:
- Acute organophosphorus poisoning is a significant global health concern, often leading to respiratory compromise.
- Laryngeal dysfunction, characterized by impaired vocal cord movement and airway protection, is a potential but under-recognized complication.
Discussion:
- This case highlights the critical importance of considering laryngeal dysfunction in patients presenting with acute organophosphorus poisoning.
- Neuromuscular blockade from organophosphates can affect laryngeal muscles, leading to symptoms like stridor and aspiration risk.
- Prompt diagnosis and intervention, including airway support, are vital for preventing severe respiratory distress and improving prognosis.
Key Insights:
- Organophosphate exposure can directly impair laryngeal function, contributing to airway obstruction.
- Clinical vigilance for laryngeal abnormalities is essential in managing poisoned patients.
- Integrated care involving toxicology and critical care expertise improves patient safety.
Outlook:
- Further research is warranted to elucidate the precise mechanisms of organophosphate-induced laryngeal dysfunction.
- Developing specific diagnostic tools and treatment protocols for this complication could enhance patient care.
- Educational initiatives for healthcare providers on this specific poisoning manifestation are recommended.
Related Concept Videos
01:26Anticholinesterase Agents: Poisoning and Treatment
1.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.0K
01:22Indirect-Acting Cholinergic Agonists: Pharmacokinetics
1.1K
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
1.1K
01:21Larynx
2.1K
The human larynx, often referred to as the voice box, is an intricate organ located in the neck. It serves as a pathway for air to enter the lungs during respiration and is an essential component of voice production.
Anatomy of the Larynx
The larynx consists of various components, including cartilage, muscles, and vocal cords. Its structure includes three large unpaired cartilages—the thyroid, cricoid, and epiglottis—and three smaller paired cartilages—the arytenoids,...
Anatomy of the Larynx
The larynx consists of various components, including cartilage, muscles, and vocal cords. Its structure includes three large unpaired cartilages—the thyroid, cricoid, and epiglottis—and three smaller paired cartilages—the arytenoids,...
2.1K
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
643
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
643
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.3K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.3K
01:19Depolarizing Blockers: Pharmocokinetics
377
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
377